Naftali Kaminski
Section Chief, Pulmonary, Critical Care & Sleep Medicine Yale School of Medicine
Dr. Naftali Kaminski is the Boehringer Ingelheim Endowed Professor of Internal Medicine and Chief of Pulmonary, Critical Care and Sleep Medicine at Yale School of Medicine. A global leader in idiopathic pulmonary fibrosis, his research focuses on applying genomic and systems biology approaches to understand disease mechanisms and advance precision medicine.
Dr. Kaminski has pioneered genome-scale transcriptomics in lung disease, identifying key molecular drivers of fibrosis and enabling biomarker-based patient stratification. His work has also highlighted novel therapeutic pathways, including the role of microRNAs and thyroid hormone signalling in fibrosis. He has authored over 300 publications in leading journals and is a highly cited figure in pulmonary research.
Widely recognised for his contributions, Dr. Kaminski has received multiple prestigious awards and is deeply committed to mentoring the next generation of physician-scientists in genomics and translational lung disease research.
Seminars
- Exploring the key cell populations and signaling pathways that drive the onset of pulmonary fibrosis in humans
- Identifying the molecular drivers, including transcriptional and epigenetic programs, that initiate fibrotic remodeling
- Detailing how understanding early disease mechanisms can inform biomarker discovery, patient stratification, and development of targeted interventions
